Syngene International quarterly results and financials

Syngene International (SYNGENE)₹436.90+0.51%(9 Nov 2026 close)Healthcare Research, Analytics & Technology

Key facts

In the Sep 2026 quarter (consolidated), Syngene International reported sales of ₹836 Cr, down 8.6% from Sep 2025, and net profit of ₹32.09 Cr, down 52.2% year on year. For the year to Mar 2026, sales were ₹3,753 Cr and net profit ₹318 Cr.

Sales (Sep 2026): ₹836 Cr
Net profit (Sep 2026): ₹32.09 Cr
Sales (FY Mar 2026): ₹3,753 Cr
Net profit (FY Mar 2026): ₹318 Cr
EPS (Sep 2026): ₹0.81
Borrowings (Mar 2026): ₹458 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Syngene International quarterly results

₹ crore unless stated; each column is a quarter.

Syngene International Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	858	920	793	894	947	1,022	878	914	920	1,040	738	836
Expenses	621	599	619	645	658	673	667	709	706	732	644	684
Operating Profit	232	317	170	245	284	344	206	200	209	303	90.96	147
OPM %	26.9%	34.9%	22.0%	27.0%	29.9%	33.9%	23.9%	21.9%	22.9%	28.9%	11.9%	17.9%
Other Income	26.05	16.03	50.05	16.03	18.03	19.05	18.02	15.02	−55.04	16.04	12.03	21.05
Interest	11.04	13.06	12.04	13.04	12.05	16.07	12.04	13.04	12.05	12.05	10.03	10.04
Depreciation	108	111	107	111	109	106	111	116	114	112	112	112
Profit before tax	138	208	101	137	180	239	101	84.77	27.90	195	−18.94	46.86
Tax %	19.0%	10.0%	25.0%	23.1%	27.0%	24.1%	14.0%	21.1%	47.1%	25.0%	−53.0%	31.1%
Exceptional items	−2.98	0.00	23.84	0.00	0.00	0.00	0.00	0.00	−57.03	−4.52	−13.40	−4.58
Net Profit	112	190	76.21	106	131	183	87.23	67.12	15.03	148	−9.02	32.09
EPS (Rs)	2.78	4.70	1.89	2.65	3.27	4.56	2.16	1.68	0.38	3.68	−0.23	0.81

Syngene International profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Syngene International Profit and loss
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1,428	1,833	2,020	2,190	2,613	3,202	3,502	3,656	3,753	3,534
Expenses	947	1,287	1,392	1,504	1,856	2,248	2,467	2,592	2,812	2,765
Operating Profit	474	536	617	678	742	942	1,017	1,045	920	750
OPM %	32.9%	28.9%	30.9%	30.9%	28.9%	29.9%	28.9%	28.9%	24.9%	21.2%
Other Income	53.07	75.15	153	94.08	75.14	63.13	77.16	101	−9.02	−5.92
Interest	23.10	32.13	35.11	28.10	24.11	45.16	47.20	53.22	49.21	44.17
Depreciation	131	164	218	273	309	365	425	432	451	448
Profit before tax	371	414	516	468	483	593	619	658	410	251
Tax %	18.0%	20.0%	20.0%	14.0%	18.0%	22.0%	18.0%	25.1%	23.0%	—
Exceptional items	15.96	2.99	53.91	24.94	−21.95	−5.99	−10.97	53.91	−54.86	−79.53
Net Profit	306	333	413	406	397	465	511	497	318	186
EPS (Rs)	7.65	8.30	10.32	10.13	9.90	11.58	12.70	12.35	7.87	4.64
Dividend payout %	7.0%	3.0%	0.0%	0.0%	10.0%	11.0%	10.0%	10.0%	16.0%	—

Syngene International balance sheet

₹ crore, at each year end.

Syngene International Balance sheet
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	200	200	400	400	401	401	402	402	403
Reserves	1,518	1,766	1,775	2,418	2,896	3,215	3,852	4,323	4,435
Borrowings	787	813	774	892	1,021	815	555	578	458
Other Liabilities	684	926	1,220	1,175	1,251	1,405	1,345	1,498	1,765
Total Liabilities	3,191	3,707	4,169	4,885	5,568	5,836	6,154	6,803	7,062
Fixed Assets	1,030	1,376	2,021	2,199	2,393	2,667	2,847	2,801	3,001
CWIP	155	275	235	238	347	177	840	1,269	1,049
Investments	158	718	778	703	1,037	921	549	649	743
Other Assets	1,847	1,339	1,135	1,744	1,791	2,071	1,918	2,083	2,269
Inventories	86.07	43.05	25.01	60.03	179	333	238	156	141
Trade receivables	268	340	399	477	509	530	443	528	510
Cash & equivalents	964	436	281	641	517	530	562	785	830
Total Assets	3,191	3,707	4,169	4,885	5,568	5,836	6,154	6,803	7,062

Syngene International cash flow

₹ crore, for each year.

Syngene International Cash flow
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	446	631	678	702	581	825	1,043	1,169	916
Cash from investing activity	−348	−644	−422	−627	−609	−651	−493	−741	−835
Cash from financing activity	−79.07	−72.04	−226	58.04	−31.06	−343	−552	−142	−215
Net cash flow	18.06	−88.26	28.09	130	−62.20	−173	−4.01	282	−138
Capex	364	583	643	446	476	517	510	769	368
Free cash flow	82.33	47.16	34.12	256	105	306	555	399	549
CFO / OP %	111.0%	135.0%	127.0%	116.0%	92.0%	102.0%	115.0%	123.0%	107.0%

Syngene International ratios

Working-capital days and returns, by year.

Syngene International Ratios
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	68	68	72	79	71	61	46	53	50
Inventory days	83	31	19	42	88	142	95	61	57
Days payable	195	154	156	167	113	109	100	136	138
Cash conversion cycle	−44	−56	−66	−47	45	92	40	−23	−32
Working capital days	−48	−103	−172	−66	−43	−14	−27	−51	−68
ROCE %	—	17.1%	17.1%	14.1%	13.1%	15.1%	15.1%	13.0%	10.0%

Syngene International: frequently asked questions

What are the latest quarterly results of Syngene International?

For the Sep 2026 quarter, Syngene International reported sales of ₹836 Cr, down 8.6% year on year and net profit of ₹32.09 Cr, down 52.2% year on year. The operating margin was 17.9%.

What is the annual revenue of Syngene International?

Syngene International's sales for the year to Mar 2026 were ₹3,753 Cr; over the last twelve months they were ₹3,534 Cr.

What is the net profit of Syngene International?

Net profit for the year to Mar 2026 was ₹318 Cr, and ₹186 Cr over the last twelve months. Earnings per share over the same trailing period were ₹4.64.

How much debt does Syngene International have?

Syngene International reported borrowings of ₹458 Cr at Mar 2026, against cash and equivalents of ₹830 Cr.

What is the free cash flow of Syngene International?

Cash from operations was ₹916 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹549 Cr.

Loading…